top of page

Home > Package Inserts > Priorix

Priorix

Childhood vaccine given at 1 year old.

Intramuscular injection.

Download package insert
Australia
Europe
USA

Manufactured by GlaxoSmithKline Biologicals

  • Measles virus Schwarz strain (live, attenuated)

  • Mumps virus RIT 4385 strain derived from the Jeryl Lynn strain (live, attenuated)

  • Rubella virus Wistar RA 27/3 strain (live, attenuated)

1 dose (0.5 ml) also contains:

Anhydrous lactose (32 mg) - a milk sugar. People who are specifically "allergic" to lactose (not just lactose intolerant) should not use medications containing lactose, or ask their health care provider prior to use.

Sorbitol (9 mg) - a sugar alcohol with a sweet taste, a naturally occurring sweetener synthetically extracted from glucose.

Amino acids (9 mg) - organic molecules used by all living things to make proteins. 

Mannitol (8 mg) - a sugar alcohol used to test for asthma, to reduce intracranial and intraocular pressure, to measure glomerular filtration rate, and to manage pulmonary symptoms associated with cystic fibrosis. Mannitol may also be used for the promotion of diuresis before irreversible renal failure becomes established. (1)

Residuals from the manufacturing process:

Neomycin sulphate (≤25 mcg) - antibiotic class of drugs.

Ovalbumin (≤60 ng) - the major protein component of egg white.

Bovine serum albumin (≤50 ng) - a serum albumin protein derived from cows.

WARNINGS AND PRECAUTIONS

Febrile Seizures
There is a risk of febrile seizure following immunization with PRIORIX.

Thrombocytopenia

Thrombocytopenia and thrombocytopenic purpura have been reported following vaccination with PRIORIX.

Pregnancy
Do not administer PRIORIX to individuals who are pregnant. Pregnancy should be avoided for 1 month following vaccination.

PRIORIX contains the Schwarz strain of live attenuated measles virus, the RIT 4385 strain of live attenuated mumps virus (derived from the Jeryl Lynn strain), both propagated in chick-embryo fibroblasts from embryonated eggs of specific pathogen-free flocks and the Wistar RA 27/3 strain of live attenuated rubella virus propagated in MRC-5 human diploid cells.

Carcinogenesis, Mutagenesis, Impairment of Fertility
PRIORIX has not been evaluated for carcinogenic or mutagenic potential or for impairment of fertility.

Frequencies per dose are defined and colour coded as follows:

Very common - (≥1/10)

Common - ≥1/100 to <1/10

Uncommon - ≥1/1,000 to <1/100

Rare - ≥1/10,000 to <1/1,000

Very rare - <1/10,000

Side effects that are not colour coded are of unknown frequency.

Side effects in trials
Side effects postmarketing

Haematologic/ Lymphatic

Anaemia

Lymphadenopathy

Nervous system disorders

Nervousness

Insomnia

Febrile convulsions

Respiratory disorders

Pharyngitis

Bronchitis

Coughing

Respiratory disorder

Other upper respiratory tract infection

Rhinitis

Pneumonia

Laryngitis

Stridor

Gastrointestinal disorders

Diarrhoea

Anorexia

Gastrointestinal disorder

Parotid gland enlargement

Toothache

Vomiting

Enteritis

Gastroenteritis

Stomatitis

Stomatitis aphthous

Skin and appendage

Rash

Dermatitis

Eczema

Pruritis

Herpes simplex

Herpes zoster

 

Special Senses

Otitis media

Conjunctivitis

General disorders and administration site conditions

Redness at the injection site

Fever ≥ 38°C (rectal) or ≥ 37.5°C (axillary/oral)

Pain and swelling at the injection site

Fever > 39.5°C (rectal) or >39°C (axillary/oral)

Viral infection

Injury

Infection

Allergy

Abnormal crying

Fatigue

Infection bacterial

Infection fungal

Infections and infestation

Meningitis

Measles-like syndrome

Mumps-like syndrome (including orchitis, epididymitis and parotitis)

Blood and lymphatic system disorders

Thrombocytopenia

Thrombocytopenic purpura

Immune system disorders

Anaphylactic reactions

Nervous system disorders

Encephalitis

Cerebellitis

Cerebellitis like symptoms (including transient gait disturbance and transient ataxia)

Guillain Barré syndrome

Transverse myelitis

Peripheral neuritis

Afebrile seizures

Syncope

Vascular disorders

Vasculitis (including Henoch Schonlein purpura and Kawasaki syndrome)

Skin and subcutaneous tissue disorders

Erythema multiforme

Musculoskeletal and connective tissue disorders

Arthralgia

Arthritis

*side effect list is a combination of Priorix Europe, Canada and USA.

Manufacturer's Pacakge Insert Side Effects*

References

1. Drugbank  https://go.drugbank.com/drugs/DB00742

bottom of page